Chiral Drugs – S Amlodipine, Calcium channel Blocker

Home : Chiral Drugs >> S-amlodipine

Asomex - International Tie-ups / Presence

Therapeutic category: Calcium channel blocker

Composition:
Each uncoated tablet contains S-amlodipine besylate equivalent to S-amlodpine … 2.5 mg/ 5 mg

Indication: Hypertension, angina

Dose (adults): 2.5 – 5 mg once daily

Advantages:

Provides the active CCB component only
Half the racemate dose
Less metabolic load
Consistent pharmacokinetics
Prevents accumulation of R-amlodipine
Causes negligible pedal edema.

Disclaimer: The information on this page is for the use only of a registered medical practitioner or a hospital or a laboratory only. Expert medical advice must be taken before consuming any medicine. The information on this page should not be construed as medical advice, a medical opinion or diagnosis. Emcure will not be liable for any such interpretation. As medical information and treatment guidelines are constantly evolving and changing, the prescriber is requested to update his/her information regularly before prescribing. Any consequence due to lack of such updation will not be Emcure’s liability.

Home | Company Profile | Feedback | Contact Us | Sitemap.

This information contained in the website should not be construed as medical advice, a medical opinion or diagnosis. Emcure Pharmaceuticals Limited shall not be liable for any such interpretation and any action taken on the basis of such interpretation and consequences arising therefrom. As medical information and treatment guidelines are constantly evolving and changing, the prescriber is requested to update his/her information regularly before prescribing the medicines/products as mentioned in this website.

Emcure Pharmaceuticals Limited shall not be liable for any consequence due to lack of such updation. Emcure Pharmaceuticals Limited shall not be held liable for any damage or injury or liability or compensation or claim arising from any unauthorized or improper or un-advised or off-label or mis-diagnosed use of the medicines/products mentioned in this website or for any adverse effects arising out of any use, whether or not such reactions are documented in the published literature or prescribing information or are unexpected and not published hitherto including carcinogenicity, mutagenicity, any effect on fertility or pregnancy, any effect on pregnant women, nursing mothers, pediatric or geriatric patients. Emcure Pharmaceuticals Limited shall not be held liable for any adverse consequences of improper storage of the medicines/products by the doctor, patient, pharmacies or any other distribution partners.

All content related to Emcure Pharmaceuticals Limited’s corporate and business activities, as well as those of its associates included on Emcure Pharmaceuticals Limited’s site as well as on associated sites, such as text, graphics, logos, button icons, images, audio clips and software, is the exclusive property of Emcure Pharmaceuticals Limited and / or its associates, and is protected by applicable legislations concerning protection and preservation of intellectual property rights and international treaties relating thereto. The compilation (meaning the collection, arrangement and assembly) of all content on this site is also the exclusive property of Emcure Pharmaceuticals Limited and/ or its associates and is protected by applicable laws as stated above.